| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,049 |
1,359 |
$97K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,911 |
1,238 |
$69K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
388 |
281 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
875 |
573 |
$6K |
| 99215 |
Prolong outpt/office vis |
87 |
62 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
123 |
102 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
268 |
189 |
$3K |
| 99000 |
|
324 |
260 |
$882.00 |
| 36415 |
Collection of venous blood by venipuncture |
534 |
394 |
$628.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15 |
12 |
$560.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
23 |
21 |
$553.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
287 |
208 |
$331.27 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
259 |
196 |
$45.21 |
| 3079F |
|
342 |
242 |
$0.00 |
| 3074F |
|
853 |
520 |
$0.00 |
| 3080F |
|
261 |
181 |
$0.00 |
| 3075F |
|
176 |
115 |
$0.00 |
| 81000 |
|
20 |
13 |
$0.00 |
| 3078F |
|
845 |
509 |
$0.00 |
| 3077F |
|
320 |
224 |
$0.00 |